Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the complete SE multicenter trial

Journal of Endovascular Therapy

Volumn 21, Issue 2, 2014, Pages 202-212

  Laird, John R ^a   Jain, Ash ^b   Zeller, Thomas ^c   Feldman, Robert ^d   Scheinert, Dierk ^e   Popma, Jeffrey J ^f   Armstrong, Ehrin J ^a   Jaff, Michael R ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Washington Hospital   (United States)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d Munroe Regional Med Center   (United States)

^e UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPUTATION; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTERY CALCIFICATION; ARTERY LESION; ARTERY OCCLUSION; ARTICLE; BYPASS SURGERY; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DISEASE SEVERITY; FALSE ANEURYSM; FEMALE; FOLLOW UP; GRAFT PATENCY; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIA; ISCHEMIC REST PAIN; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; NITINOL STENT; POPLITEAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROXIMAL POPLITEAL ARTERY; QUALITY OF LIFE; STENT FRACTURE; SUPERFICIAL FEMORAL ARTERY; BLOOD FLOW VELOCITY; CHRONIC DISEASE; CLINICAL TRIAL; CONVALESCENCE; EUROPE; FEMORAL ARTERY; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; PROSTHESIS; RADIOGRAPHY; STENT; TIME; TREATMENT OUTCOME; UNITED STATES; VASCULAR CALCIFICATION; VASCULAR PATENCY;

ALLOY; NITINOL;

AGED; ALLOYS; ANGIOPLASTY, BALLOON; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; CHRONIC DISEASE; EUROPE; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR CALCIFICATION; VASCULAR PATENCY;

EID: 84899425814     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/13-4548R.1     Document Type: Article

References (26)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
2. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing longterm success. Circulation. 1991;83:I70-I80.
3. Rocha-Singh KJ, Jaff MR, Crabtree TR, et al. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910-919. (Pubitemid 46867500)
4. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther. 2006;13 Suppl 2:II30-40. (Pubitemid 43273488)
5. Jeans WD, Armstrong S, Cole SE, et al. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology. 1990;177:559-564. (Pubitemid 20374885)
6. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311. (Pubitemid 36314758)
7. Hewes RC, White RI, Murray RR, et al. Long-term results of superficial femoral artery angioplasty. AJR Am J Roentgenol. 1986;146:1025-1029. (Pubitemid 16120020)
8. Murray RR, Hewes RC, White RI, et al. Long-segment femoropopliteal stenoses: is angioplasty a boon or a bust? Radiology. 1987;162:473-476. (Pubitemid 17015657)
9. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
10. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
11. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005;12:676-684. (Pubitemid 43100925)
12. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315. (Pubitemid 40094743)
13. Popma JJ, Tiroch K, Almonacid A, et al. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimuseluting stent implantation. Am J Cardiol. 2009;103:923-929.
14. Nikanorov A, Smouse HB, Osman K, et al. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg. 2008;48:435-440.
15. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
16. Scheinert D, Grummt L, Piorkowski M, et al. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18:745-752.
17. Hu H, Zhang H, He Y, et al. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result. Ann Vasc Surg. 2011;25:210-216.
18. Zeller T, Tiefenbacher C, Steinkamp HJ, et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther. 2008;15:390-398.
19. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-710. (Pubitemid 44907633)
20. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285-292. (Pubitemid 47196564)
21. Dake MD, Ansel GM, Jaff MR, et al. Paclitax-eleluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504.
22. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699. (Pubitemid 351240748)
23. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
24. Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoropopliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012;5:831-840.
25. Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions. J Am Coll Cardiol. 2013;61:2417-2427.
26. Schlager O, Francesconi M, Haumer M, et al. Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a "real-world" setting. J Endovasc Ther. 2007;14:452-459. (Pubitemid 350154990)